title: Preliminary observations from preliminary trial results: have we finally had enough?
authors.affiliation: Cardiology Service, Walter Reed Army Medical Center, Washington, DC 20307-5001, USA. allen.taylor@amedd.army.mil
authors.forename: Allen J
authors.initials: AJ
authors.lastname: Taylor
authors.forename: Steven E
authors.initials: SE
authors.lastname: Nissen
mesh_terms: D000328:Adult; D000924:Anticholesteremic Agents / Q000008:administration & dosage / Q000009:adverse effects*; D001024:Aortic Valve Stenosis / Q000150:complications / Q000188:drug therapy* / Q000453:epidemiology / Q000503:physiopathology; D001384:Azetidines / Q000008:administration & dosage / Q000009:adverse effects*; D013504:Cardiovascular Surgical Procedures / Q000706:statistics & numerical data; D000069438:Ezetimibe; D006333:Heart Failure / Q000209:etiology / Q000517:prevention & control; D006801:Humans; D015994:Incidence; D009369:Neoplasms / Q000139:chemically induced* / Q000453:epidemiology / Q000517:prevention & control; D016032:Randomized Controlled Trials as Topic; D015427:Reperfusion Injury / Q000209:etiology / Q000517:prevention & control; D012107:Research Design; D019821:Simvastatin / Q000008:administration & dosage / Q000009:adverse effects*; D016019:Survival Analysis; D016896:Treatment Outcome
chemical_list: D000924:Anticholesteremic Agents; D001384:Azetidines; D019821:Simvastatin; D000069438:Ezetimibe